Real‐World Evaluation of Botulinum Toxin A in Focal Peripheral Neuropathic Pain: Longitudinal Outcomes
This real-life study over 1 year suggests that BT-A provides progressive and sustained benefit in focal peripheral NP, supporting continued treatment beyond two cycles.
Authors
- Michel Lantéri‐Minet (ORCID: https://orcid.org/0000-0001-6717-9234)
- Eva Solecruz
- Anne Donnet (ORCID: https://orcid.org/0000-0003-0034-5247)
- Chloé Hirtz
- Elise Van Obberghen‐Blanc
- Imene Bennour
Institutions
- Aix-Marseille Université (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/ene.70362
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39